Please join us at theJoint Conference of European Human Pharmacological Societies CLUB PHASE I (France), AGAH (Germany), BAPU (Belgium), AHPPI (UK)11 & 12 April 2013Nice Sophia Antipolis, FranceThe meeting will focus on Early Clinical Utility Assessment of new medicines and how early development should be conducted to optimize the challenging process of reaching efficient and early go/no go decisions.Be part of this European meeting featuring first class plenary sessions and interactive workshops and experience excellent networking opportunities in stimulating surroundings.View programmeRegister online

Please forward this invitation to interested colleagues also.Looking forward to seeing you!Sincerely yoursConference ChairDr. Yves DonazzoloPresident CLUB PHASE IIntercom Kongresse GmbHAntje BlmekeEppendorfer Baum 39a20249 Hamburg (Germany)Phone: +49 40 480610 61Telefax: +49 40 480610 66E-Mail: abloemeke@intercom.deWeb: www.intercom..de

Disclaimer 2013 Intercom Kongresse GmbHEppendorfer Baum 39a, 20249 Hamburg/GermanyUSt-ID DE 1615 400 24, Registry court Hamburg, HRB 113503. All rights reserved. Responsible for contents pursuant to 6 MDStV Managing Director Alexandra Werner.

Latest news

Richmond Pharmacology Appoints Patrick Ramiah as Director of Clinical Project Delivery & Operational Excellence

September 1, 2025
Richmond Pharmacology is delighted to announce the promotion of Patrick Ramiah to the role of Director of Clinical Project Delivery & Operational Excellence, effective from 1 September 2025.
Read more

Events

JSCPT 2025

5 – 6 December 2025
Richmond Pharmacology will attend JSCPT 2025 in Tokyo, represented by their leadership team. Topics include early-phase studies, bridging studies between Europe and Asia, gene and RNA-based therapy development, and cross-border collaboration.
View event